Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 172-179

  Otto, Gisela ^a   Braconier, Jean Henrik ^a   Andreasson, Annika ^a   Svanborg, Catharina ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CEFTAZIDIME; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; BODY TEMPERATURE; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYELONEPHRITIS; URINARY TRACT INFECTION; URINE CULTURE;

ACUTE-PHASE REACTION; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; FEVER; HUMANS; INTERLEUKIN-6; KINETICS; MALE; MIDDLE AGED; URINARY TRACT INFECTIONS;

EID: 0032952663     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314534     Document Type: Article

References (39)

1. Kunin CM. Urinary tract infections: detection, prevention, management. 5th ed. Baltimore: Williams & Wilkins, 1997.
2. Gleckman RA, Bradley PJ, Roth RM, Hibert DM. Bacteremic urosepsis: a phenomenon unique to elderly women. J Urol 1985; 133:174-5.
3. Grover SA, Komaroff AL, Weisberg M, Cook EF, Goldman L. The characteristics and hospital course of patients admitted for presumed acute pyelonephritis. J Gen Intern Med 1987;2:5-10.
4. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988;85:793-8.
5. Sandberg T, Englund G, Lincoln K, Nilsson LG. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis 1990;9:317-23.
6. Otto G, Sandberg T, Marklund BI, Ulleryd P, Svanborg C. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with and without bacteremia. Clin Infect Dis 1993;17:448-56.
7. Ikäheimo R, Siitonen A, Kärkkäinen U, Mustonen I, Heiskanen T, Mäkelä PM. Community-acquired pyelonephritis in adults: characteristics of E. coli isolates in bacteremic and non-bacteremic patients. Scand J Infect Dis 1994;26:289-96.
8. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-69.
9. de Man P, van Kooten C, Aarden L, Engberg I, Svanborg-Edén C. Interleukin-6 induced at mucosal surfaces by Gram-negative bacterial infection. Infect Immun 1989;57:3383-8.
10. Hedges S, Andersson P, Lidin-Janson G, de Man P, Svanborg C. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun 1991;59:421-7.
11. Hedges S, Stenqvist K, Lidin-Janson G, Martinell J, Sandberg T, Svanborg C. Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis and asymptomatic bacteriuria. J Infect Dis 1992;166:653-6.
12. Agace W, Hedges S, Ceska M, Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 1993;92:780-5.
13. Benson M, Jodal U, Andreasson A, Karlsson Å, Rydberg J, Svanborg C. Interleukin-6 response to urinary tract infection in childhood. Pediatr Infect Dis J 1994;13:612-6.
14. Hedges S, Svensson M, Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 1992;60:1295-301.
15. Ko YC, Mukaida N, Ishiyama S, et al. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 1993;61:1307-14.
16. Nicolle LE, Brunka J, Orr P, Wilkins J, Harding GK. Urinary immunoreactive interleukin-1 alpha and interleukin-6 in bacteriuric institutionalized elderly subjects. J Urol 1993;149:1049-53.
17. Tullus K, Fituri O, Burman LG, Wretlind B, Brauner A. Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis. Pediatr Nephrol 1994;8:280-4.
18. Jacobson SH, Hylander B, Wretlind B, Brauner A. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron 1994;67:172-9.
19. Tullus K, Fituri O, Linnè T, et al. Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis in relation to DMSA-scintigraphy in the acute phase and at 1-year follow-up. Pediatr Radiol 1994;24:513-5.
20. Ohta K, Takano N, Seno A, et al. Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract. Clin Nephrol 1992;38:185-9.
21. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621-36.
22. Helle M, Brakenhoff JP, De Groot ER, Aarden LA. Interleukin-6 is involved in interleukin-1 induced activities. Eur J Immunol 1988;18:957-9.
23. Gauldie J, Richards C, Harnish D, Landsdorp P, Baumann H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte derived hepatocyte-stimulatory factor and regulates the major acute phase response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-5.
24. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992;258:593-7.
25. Hamilton-Miller JMT. Urinary tract infections. Curr Opin Infect Dis 1997;10:66-9.
26. Hang L, Svanborg C, Andersson G. Determination of interleukin 6 in human urine and epithelial cell supernatants. Int Arch Allergy Immunol 1994;105:397-403.
27. Hedges S, de Man P, Linder H, van Kooten C, Svanborg-Éden C. Interleukin-6 is secreted by epithelial cells in response to Gram-negative bacterial challenge. In: MacDonald T, ed. Advances in mucosal immunology. London: Kluwer, 1990:144-8.
28. Hedges S, Agace W, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 1995;3:266-70.
29. Hedlund M, Svensson M, Nilsson Å, Duan RD, Svanborg C. Role of ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996;183:1037-44.
30. Linder H, Engberg I, Mattsby-Baltzer I, Jann K, Svanborg-Edén C. Induction of inflammation by Escherichia coli on the mucosal level: requirement for adherence and endotoxin. Infect Immun 1988;56:1309-13.
31. de Man P, Jodal U, Lincoln K, Svanborg-Edén C. Bacterial attachment and inflammation in the urinary tract. J Infect Dis 1988;158:29-35.
32. Johnson J. Host-pathogen interactions in Escherichia coli urinary tract infections. Curr Opin Infect Dis 1994;7:287-94.
33. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995;172:886-91.
34. Kragsbjerg P, Holmberg H, Vikerfors T. Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand J Infect Dis 1996;28:391-8.
35. Calandra T, Gerain J, Heumann D, Baumgartener JD, Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991;91:23-9.
36. Dofferhoff AS, Bom VJ, de Vires-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992;20:185-92.
37. Söderquist B, Sundqvist KG, Vikerfors T. Kinetics of serum levels of interleukin-6 in Staphylococcus aureus septicemia. Scand J Infect Dis 1992;24:607-12.
38. Frieling JT, van Deuren M, Wijdenes J, et al. Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis 1995;171:469-72.
39. Gårdlund B, Sjölin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995;172:296-301.